Search

Your search keyword '"Hymes, Kenneth B."' showing total 43 results

Search Constraints

Start Over You searched for: Author "Hymes, Kenneth B." Remove constraint Author: "Hymes, Kenneth B."
43 results on '"Hymes, Kenneth B."'

Search Results

3. Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma

4. Leveraging Pre-Clinical Animal Model of CTCL to Explore Therapeutic Potential of a Novel STAT3 Degrader

7. A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma

8. Cytopenias in Transplant Patients

13. Skin Associated Staphylococcus Aureus Contributes to Disease Progression in CTCL

15. STAT3 dysregulation in mature T and NK cell lymphomas

17. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients

18. Final Results of a CTEP Sponsored Phase I Study of Alistertib in Combination with Bortezomib and Rituximab in Relapsed and Refractory Mantle Cell and Low Grade Non-Hodgkin Lymphoma

19. Midostaurin in Combination with Idarubicin and Cytarabine (3+7) Induction for FLT3 Positive AML - Very High Complete Response Rates and Transition to Allogeneic Transplantation

20. Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma

21. Hodgkin Lymphoma Patients Demonstrate Evidence of Systemic Perturbation of the Monocyte-Dendritic Cell Axis

23. Circulating Memory T Cells Isolated from Hodgkin Lymphoma Patients Display Evidence of Exhaustion and Chronic Activation

24. A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma

27. Denileukin diftitox for the treatment of cutaneous T-cell lymphoma

32. Final Results of a Phase II Trial of Belinostat (PXD101) in Patients with Recurrent or Refractory Peripheral or Cutaneous T-Cell Lymphoma.

34. Zanolimumab, a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in Patients with CD4+ Mycosis Fungoides (MF) Type CTCL (Stage IB-IVB) Who Are Refractory or Intolerant to Targretin and One Other Standard Therapy.

35. Choices in Treatment Cutaneous Lymphoma the of T-Cell.

37. Regulation of Autoimmune Anti-Platelet Antibody-Mediated Adhesion of Monocytes to Platelet GPIIb/GPIIIa: Effect of Armed Monocytes and the Mac-1 Receptor

38. Skin Associated Staphylococcus AureusContributes to Disease Progression in CTCL

40. Zanolimumab, a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in Patients with CD4+Mycosis Fungoides (MF) Type CTCL (Stage IB-IVB) Who Are Refractory or Intolerant to Targretin and One Other Standard Therapy.

41. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic FANCA variant.

42. STAT3 Dysregulation in Mature T and NK Cell Lymphomas.

43. Choices in the treatment of cutaneous T-cell lymphoma.

Catalog

Books, media, physical & digital resources